Buy Propofol Fresenius vials 20 mg/ml, 50 ml
  • Buy Propofol Fresenius vials 20 mg/ml, 50 ml

Propofol

Fresenius Kabi
Dosage form
Brand & Manufacturer
Package Size
$48.56
Quantity
There are not enough products in stock
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Propofol - high-speed intravenous anesthetic for introduction into general anesthesia and its maintenance, as well as for sedation of patients during intensive therapy.

According to the general opinion, this anesthetic causes a non-specific effect at the level of lipid membranes. In most patients, general anesthesia occurs in 30-60 seconds.

The duration of anesthesia, depending on the dose and concomitant medications, is from 10 minutes to 1 hour. From anesthesia, the patient awakens quickly and with a clear mind. The ability to open your eyes appears after 10 minutes. Specific sites specific adsorption is not installed.

When using Propofol for induction anesthesia and for its maintenance, there is a decrease in average blood pressure and small changes in heart rate. However, hemodynamic parameters usually remain relatively stable while maintaining general anesthesia and the frequency of adverse hemodynamic changes is low.

Although after the introduction of Propofol, respiratory depression can occur, any effects qualitatively similar to those that occur with the use of other intravenous anesthesia, and are easily controlled in a clinical setting.

Propofol reduces cerebral blood flow, intracranial pressure and reduces cerebral metabolism. The decrease in intracranial pressure was significantly in patients with an elevated baseline intracranial pressure.

Indications

Propofol applied:

  • in adults and children older than 1 month for general intravenous anesthesia, which has a short-term effect;
  • in adults and children older than 1 month for induction anesthesia and for its maintenance;
  • in adults and children older than 16 years to ensure sedation, receiving intensive therapy and being on a ventilator;
  • in adults who are conscious, in order to ensure a sedative effect during surgical and diagnostic procedures.

Composition

1 ml of emulsion contains: propofol 10 mg;
excipients: soybean oil, egg lecithin, glycerin, oleic acid, sodium hydroxide, water for injection

Propofol is marketed under different brands and generic names, and comes in different dosage forms:

Brand nameManufacturerCountryDosage form
Propofol Fresenius Fresenius Kabi Germany vials
Propofol Fresenius Kabi Germany ampoules
Diprivan AstraZeneca UK emulsion
Propofol-Lipuro B. Brown Medical AG Germany emulsion

No customer reviews for the moment.

Write your review

Write your review

Propofol

Dosage and Administration

IV, the dose is set individually.

General anesthesia for adults.

Introductory anesthesia: Adults — 20–40 mg every 10 seconds until signs of anesthesia appear. Patients aged up to 55 years usually need from 1.5 to 2.5 mg / kg, over 55 years old and patients of classes III and IV for ASA, especially with heart failure — the dose should be reduced to 1 mg / kg and the rate of administration should be reduced ( 20 mg every 10 s). Children over 3 years old - slowly until clinical signs of anesthesia appear. The dose is adjusted in accordance with the age and (or) body weight of the child. Children over 8 years old are likely to take 2.5 mg / kg. Older children may require a higher dose. A lower dose is recommended for grade III and IV children with ASA. Not recommended for use in children under 3 years.

Maintenance of anesthesia: for adults - in the form of continuous infusion or repeated bolus injections. With prolonged infusion, the dose is usually in the range of 6–12 mg / kg.

Elderly patients, patients with severe general condition, patients of grades III and IV of the ASA and patients with hypovolemia reduce the dose to a minimum of 4 mg / kg / h. Bolusno enter from 25 to 50 mg of the drug.

Children over 3 years old - as a permanent infusion or bolus injections, usually satisfactory anesthesia is provided at a rate of 9–15 mg / kg / h.

Achievement of sedation: during intensive therapy, prolonged infusion at a rate of 0.3–0.4 mg / kg / h is recommended for patients on artificial respiration; in diagnostic and surgical procedures, depending on the clinical picture, usually 0.5–1 mg for 1–5 minutes to achieve the effect and 1.5–4.5 mg / kg / h to maintain. For fast achievement of deep sedation - bolus 10–20 mg.

Do not use in children under 16 years of age during surgical and diagnostic procedures to achieve a sedative effect.

Do not use the drug during pregnancy and during breastfeeding, as well as an anesthetic in obstetrics.

It should not be mixed with other injection solutions, except for 5% glucose solution, lidocaine solution for injection, fentanyl solution for injection.

Adverse reactions

Seldom:

  • convulsions
  • opisthotonus,
  • pulmonary edema.

Contraindications

Hypersensitivity to one of the components of the drug, children up to 1 month.

Propofol contraindicated for sedation of patients under the age of 16 years during intensive therapy.

Drug interactions

Compatible with drugs for spinal and epidural anesthesia, with drugs used during sedation, with muscle relaxants and analgesics.

Pregnancy and Lactation

Contraindicated in pregnancy and lactation.

Special instructions

In cases where there is a likelihood of side effects associated with the activation of the vagus nerve, it is advisable before the introduction of anesthesia IV the introduction of anticholinergic. Should not be used in obstetric practice.

The risk of pain along the vein can be significantly reduced when conducting infusions through veins of large diameter or with the simultaneous introduction of a solution of lidocaine.

The injection can be done only by specially trained personnel, with the possibility of the immediate use of mechanical ventilation, oxygen therapy, resuscitation measures in full.

  • Brand name: Propofol Fresenius
  • Active ingredient: Propofol
  • Dosage form: Emulsion for intravenous injection.
  • Manufacturer: Fresenius Kabi
  • Country of Origin: Germany

Studies and clinical trials of Propofol (Click to expand)

  1. Selective toxicity of the general anesthetic propofol for GABAergic neurons in rat brain cell cultures
  2. Chromatographic assay and pharmacokinetic studies of propofol in human serum
  3. GLUCURONIDATION OF DIFLUNISAL, (−)-MORPHINE, 4-NITROPHENOL, AND PROPOFOL IN LIVER MICROSOMES OF TWO PATIENTS WITH CRIGLER–NAJJAR SYNDROME TYPE I
  4. Differences in responses to propofol in elderly and young adult WISW rats
  5. In vivo microdialysis evidence that midazolam facilitates propofol-induced reduction in rat accumbal dopamine release
  6. Comparison of evoked cortical activity in conscious and propofol-anesthetized rats using functional MRI
  7. Detection of new propofol metabolites in human urine using gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry techniques
  8. Determining the influence of storage time on the level of propofol in blood samples by means of chromatography
  9. The advantages of cell lysis before blood sample preparation by extraction for HPLC propofol analysis
  10. Effect of dexmedetomidine on propofol requirements in healthy subjects
  11. Propofol in subanesthetic doses terminates status epilepticus in a rodent model
  12. Feedforward adaptive control of the Bispectral Index of the EEG using the intravenous anaesthetic drug propofol
  13. The Action Sites of Propofol in the Normal Human Brain Revealed by Functional Magnetic Resonance Imaging
  14. The Action Sites of Propofol in the Normal Human Brain Revealed by Functional Magnetic Resonance Imaging
  15. Effects of β-estradiol and propofol on the 4-methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9
  16. Thromboelastographic and pharmacokinetic profiles of micro- and macro-emulsions of propofol in swine
  17. Investigation of propofol renal elimination by HPLC using supported liquid membrane procedure for sample preparation
  18. HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid
  19. The influence of blood sample storage time on the propofol concentration in plasma and solid blood elements
  20. ChemInform Abstract: Water-Soluble Propofol Analogues with Intravenous Anaesthetic Activity.
  21. Actions of the general anesthetic propofol (2,6-diisopropylphenol) on the binding of [3h]nicotine to rat cortical membranes
  22. Lower levels of oxidative DNA damage and apoptosis in lymphocytes from patients undergoing surgery with propofol anesthesia
  23. Accumulation of intracellular ascorbate from dehydroascorbic acid by astrocytes is decreased after oxidative stress and restored by propofol
  24. Propofol lipemia mimicking chyle leak during neck dissection

8 other products in the same category:

arrow_upward